<DOC>
	<DOCNO>NCT02231710</DOCNO>
	<brief_summary>The purpose study determine safe dose BPX-501 gene modify T cell infuse haplo-identical stem cell transplant facilitate engraftment safety AP1903 day 7 prevent GVHD .</brief_summary>
	<brief_title>Safety Study Gene Modified Donor T Cell Infusion After Stem Cell Transplant Non-Malignant Diseases</brief_title>
	<detailed_description>This single arm dose find study evaluate safety efficacy BPX 501 infusion ( T cell genetically modify inducible Caspase 9 suicide gene ) 3x10E6 1X10E7 cells/kg follow AP1903 infusion day 7 partially mismatch , relate , T cell-depleted hematopoietic cell transplantation ( HCT ) patient non-malignant disease . The purpose clinical trial determine dose BPX 501 T cell infusion subsequent plan infusion AP1903 facilitate engraftment prevent occurrence GVHD .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Pancytopenia</mesh_term>
	<mesh_term>Hemoglobinopathies</mesh_term>
	<mesh_term>Lymphohistiocytosis , Hemophagocytic</mesh_term>
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<criteria>1 . Patient must meet eligibility criterion allogeneic transplantation 2 . Males females 3 . Age &lt; 55 year old &gt; 4 month 4 . Diagnosis nonmalignant disorder consider treatable HCT . 5 . Lack suitable conventional donor 1 . Serious organ dysfunction 2 . Pregnant breastfeed 3 . Evidence HIV infection 4 . Bovine product allergy 5 . Patients active infectious disease</criteria>
	<gender>All</gender>
	<minimum_age>4 Months</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Severe Combined Immune Deficiency</keyword>
	<keyword>Congenital T-cell Defect</keyword>
	<keyword>Congenital T-cell Deficiency</keyword>
	<keyword>Chronic Granulomatous Disease</keyword>
	<keyword>Shwachman Diamond Syndrome</keyword>
	<keyword>Diamond Blackfan Anemia</keyword>
	<keyword>Dyskeratosis Congenita</keyword>
	<keyword>Fanconi Anemia</keyword>
	<keyword>Sickle Cell Disease</keyword>
	<keyword>Thalassemia</keyword>
	<keyword>Mucopolysaccharidosis</keyword>
	<keyword>Sphingolipidoses</keyword>
</DOC>